News
11d
Money Talks News on MSNThis Vaccine Is Now Tied to a 17% Lower Dementia RiskGetting the Shingrix vaccine after the age of 50 can reduce your chances of developing the painful skin condition known as ...
If you've ever had chickenpox in your childhood, chances are you're likely to develop shingles in the future. While people might assume that shingles — a painful, blistering rash — only ...
About 1 in 3 people will get shingles, and you can get it more than once. Studies have shown that Shingrix reduces the risk of getting shingles by over 90% in people over 50. Shingrix is a ...
Vaccines seem like an improbable way to reduce the risk of developing dementia. And yet the research has been accumulating to support just such a strategy.
People who got a Shingrix vaccine were less likely to develop dementia than people who got an older vaccine. The newer vaccine contains an inactivated form of the herpes zoster virus plus an ...
Now, new research suggests that getting the shingles vaccine Shingrix may help delay the onset of dementia. Shingles, in case you’re not familiar with it, is a painful skin rash caused by the ...
Shingles vaccines – specifically Shingrix and the older Zostavax – appear to offer cognitive benefits completely separate from their intended purpose. This unexpected finding represents a rare ...
And there are a lot of people who could still get this potential bonus, as only an estimated 30% of eligible Americans have received the two-dose shingles vaccine, known as Shingrix, according to ...
DEAR DR. ROACH: I recently read this morning that the shingles vaccine, Shingrix, “may have a protective effect against dementia.” It goes on to say the studies that have been conducted so far ...
Some studies have also identified potential associations with dementia. The $1.7 million study, funded by GlaxoSmithKline (GSK), which makes Shingrix, will allow Harris to emulate two target trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results